Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-3143

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-3143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Metoprolol Succinate extended-release 25 mg tablets, packaged in a quantity of 30. The label shows the drug name, dosage form, strength, and quantity, with direction to see the package insert for use. It includes storage instructions and repackaging information by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)

Chemical structure diagram of metoprolol succinate, showing the molecular components and arrangement for this active pharmaceutical ingredient.*

FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for metoprolol succinate versus placebo. The chart compares total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across various subgroups, including geographic region, NYHA classification, ejection fraction, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension status, and heart rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.